Physician profile
Frank Vandy
NPI 1922219344
$104,251.80
in general payments reported to CMS, 2019-2025
27 companies · $2,364 in 2025
The $2,364 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $32K · 2021: $8,152 · 2022: $3,470 · 2023: $529 · 2024: $785 · 2025: $2,364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,995 · Travel and Lodging: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,995.37 |
| Travel and Lodging | $682.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $75,193.28 | 2019-2022 | |
| Medtronic Vascular, INC. | $17,637.55 | 2019-2020 | |
| Medtronic, INC. | $3,245.96 | 2021-2025 | Hawkone, Mvp, Wholey |
| Boston Scientific Corporation | $3,148.97 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention, Ekosonic |
| Penumbra, INC. | $1,460.33 | 2019-2025 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $1,132.37 | 2019-2024 | True Flow, Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm |
| Stryker Corporation | $965.78 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Limflow System |
| Abbott Laboratories | $220.52 | 2024-2025 | Jeti Peripheral Catheter, Esprit, Cardiomems |
| Lemaitre Vascular, INC. | $203.13 | 2019-2025 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Silk Road Medical, INC. | $181.40 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $162.06 | 2019-2020 | |
| Z-Medica, LLC | $138.96 | 2019 | |
| Becton, Dickinson and Company | $96.24 | 2025 | Rotarexs 6 F X 135 Cm, Lifestream, Lutonix Drug Coated Balloon |
| Veryan Medical Incorporated | $94.07 | 2020 | |
| Reflow Medical INC | $70.41 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $41.05 | 2025 | Puraply Wound Matrix, Apligraf |
| Cook Medical LLC | $36.44 | 2019-2020 | |
| Bolton Medical INC | $34.81 | 2019-2025 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Edwards Lifesciences Corporation | $30.42 | 2025 | Sapien 3 Ultra Resilia |
| Ge Healthcare | $27.80 | 2019 | |
| Abiomed | $27.41 | 2025 | |
| Mimedx Group, INC. | $19.26 | 2025 | |
| Tactile Systems Technology INC | $18.46 | 2024 | Flexitouch Plus, Entre Plus |
| Getinge USA Sales, LLC | $17.04 | 2020 | |
| Cardinal Health 200 LLC | $16.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.15 | 2024 | Xarelto |
| Kerecis Limited | $14.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Vandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.